Manufacturing

Articles

Moderna’s new facility is expected to produce 500 million vaccine doses per year.

Moderna to Select Site in Africa for $500 Million mRNA Facility 

The agency’s human medicines committee approved an additional site in West Point, Pa. in the United States for the manufacture of Janssen’s COVID-19 vaccine. 

EMA Approves Manufacturing Site for Janssen COVID-19 Vaccine

Researchers in China report test results for a microneedle patch for COVID-19 vaccine delivery.

Researchers Cite Positive Results in COVID-19 Microneedle Patch Trial

In an amendment to their existing contract manufacturing agreement, Celsian and Poly Pharm expand GEN-1 program collaboration to add clinical and commercial batches of investigational vaccine.

Celsion and Poly Pharm to Manufacture Celsion’s DNA-Based Vaccine

New data finds J&J COVID-19 vaccine and booster to provide increased protection against COVID-19. 

Real-World Evidence Shows Strong Protection from COVID-19 with J&J Vaccine and Booster

Moderna’s new single-dose vaccine will be a booster for both COVID-19 and the flu.

Moderna to Develop Combined COVID-19/Flu Vaccine

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Alternative materials, as well as supply-chain planning, are essential to ensure a reliable supply for parenteral drug packaging.

Setting a Clear Strategy for Primary Packaging

Primates inoculated with CV2CoV show improved immune response and protection from various COVID variants.

GSK and CureVac’s Second-Generation mRNA COVID-19 Vaccine Candidate Shows Promising Results in Preclinical Study

PNI expands global headquarters with a new 75,000-square-foot facility, which will include multiple GMP suites for manufacturing RNA therapeutics and vaccines.

Precision NanoSystems Expands GMP Biomanufacturing Center 

A research team at the Keck Graduate Institute will work to adapt its decade-long low-cost vaccine R&D for developing countries into a COVID-19 vaccine.

Manufacturing, Vaccines